Exabis Library
Welcome to the e-CCO Library!
P103: Identifying CES-1 positive myeloid cells with mass cytometry as a potential therapeutic target for Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P103: Minimal Clinically Important Difference (MCID) for the Ulcerative Colitis Patient-Reported Outcomes Signs and Symptoms (UC-PRO/SS) Tool
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P103: Selective M1 macrophage polarisation in Crohn’s disease in comparison to intestinal tuberculosis: a novel observation
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P103: The identification of lesion-specific gene expression in intestinal epithelial cells of ulcerative colitis by comparing colonic organoids from lesion and non-lesion parts of same patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P104 Defective metabolism mediates NK cell dysfunction in inflammatory bowel disease (IBD)
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P104: Exploring the transcriptomic miRNA signatures of Egyptian Inflammatory Bowel Disease patients
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P104: Gene expression profiles in inflamed colonic biopsies from newly diagnosed Crohn’s disease and ulcerative colitis patients differ depending on the age at diagnosis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P104: Icariin Attenuates Intestinal Inflammation through Inhibition of the Nuclear Factor-ĸB signaling
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P104: Inflammatory complications of the pouch, and therapetic requirements after colectomy in patients with ulcerative colitis. Results from the RESERVO Study of GETECCU
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P104: Monitoring inflammatory activity in Crohn’s disease: simple ultrasonographic score vs. CEUS which one to use?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P104: Rebamipide, sucralfate, and rifaximin have the suppressive effects on radiation-induced inflammation in the intestine of mouse
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P104: Risk factors associated with the negativisation of anti-HBs antibodies in inflammatory bowel disease patients
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P105 Glutathione S -transferase theta 1 protects against colitis through goblet cell differentiation via interleukin-22
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P105: An experimental examination of appetite and disordered eating in Crohn's disease patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P105: Can patients enter the ‘Standard Set’ ICHOM parameters by completing electronic questionnaires?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P105: Coping in Inflammatory Bowel Disease: insights from the Crohn’s and Colitis UK national survey
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P105: Epithelial microRNA signatures as potential biomarkers in Crohn's disease related to clinical and endoscopic activity
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P105: Human neutrophil elastase degrades the therapeutic monoclonal antibodies effective in IBD
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P105: Inhibition of cytokine release from HT-29 cells and ulcerative colitis biopsies is potentiated by combination of selective kinase inhibitors, and such effects are mimicked by TOP1210, a narrow spectrum kinase inhibitor
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P105: Treatment of the lower gastrointestinal tract Klebsiella infections by recombinant bacteriocin KvarIa
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM